Company Valuation: Sanofi

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 111,194 112,665 112,549 116,968 100,655 105,406 - -
Change - 1.32% -0.1% 3.93% -13.95% 4.72% - -
Enterprise Value (EV) 1 121,177 119,102 120,342 125,740 111,663 117,049 113,327 109,709
Change - -1.71% 1.04% 4.49% -11.2% 4.82% -3.18% -3.19%
P/E 17.8x 16.7x 20.8x 20.4x 12.9x 13.9x 11.7x 9.99x
PBR 1.62x 1.5x 1.52x 1.51x 1.41x 1.42x 1.33x 1.24x
PEG - 2.07x -1.1x 3.14x 0.3x -16.95x 0.6x 0.6x
Capitalization / Revenue 2.94x 2.62x 2.61x 2.85x 2.31x 2.18x 2.04x 1.93x
EV / Revenue 3.21x 2.77x 2.79x 3.06x 2.56x 2.42x 2.19x 2.01x
EV / EBITDA 9.95x 8.14x 8.44x 9.76x 8.22x 7.72x 6.9x 6.17x
EV / EBIT 11.3x 9.13x 9.5x 11.1x 9.19x 8.55x 7.79x 6.98x
EV / FCF 15x 14x 14.2x 21.1x 13.8x 14.5x 11.6x 10x
FCF Yield 6.68% 7.12% 7.04% 4.74% 7.24% 6.92% 8.6% 9.97%
Dividend per Share 2 3.33 3.56 3.76 3.92 4.12 4.259 4.495 4.779
Rate of return 3.76% 3.96% 4.19% 4.18% 4.98% 4.84% 5.11% 5.43%
EPS 2 4.97 5.37 4.31 4.59 6.4 6.348 7.511 8.806
Distribution rate 67% 66.3% 87.2% 85.4% 64.4% 67.1% 59.8% 54.3%
Net sales 1 37,761 42,997 43,070 41,081 43,626 48,434 51,676 54,525
EBITDA 1 12,183 14,627 14,259 12,889 13,583 15,168 16,429 17,790
EBIT 1 10,714 13,040 12,670 11,343 12,149 13,695 14,540 15,728
Net income 1 6,223 6,720 5,400 5,744 7,813 7,676 9,238 10,825
Net Debt 1 9,983 6,437 7,793 8,772 11,008 11,643 7,921 4,303
Reference price 2 88.58 89.84 89.76 93.74 82.72 87.98 87.98 87.98
Nbr of stocks (in thousands) 1,255,293 1,254,060 1,253,891 1,247,793 1,216,810 1,198,069 - -
Announcement Date 4/2/22 3/2/23 1/2/24 30/1/25 29/1/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
13.64x2.36x7.61x4.92% 115B
42.06x14.21x30.18x0.47% 1,280B
41.04x6.89x19.37x1.9% 675B
37.61x8.63x17.8x2.34% 521B
21.6x5.24x13.13x2.49% 386B
104.47x5.96x25.4x2.31% 363B
23.92x5.8x14.13x2.74% 301B
24.1x4.84x13.6x1.8% 286B
24.17x7.41x13.62x2.16% 253B
-39.88x7.38x46.48x1.95% 211B
Average 29.27x 6.87x 20.13x 2.31% 439B
Weighted average by Cap. 36.62x 8.73x 22.21x 1.77%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Sanofi

Historical PBR trend

Valuation ratios - PBR - Sanofi

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Sanofi

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Sanofi


Year-on-year evolution of the Yield

Valuation ratios - Yield - Sanofi